نتائج البحث 1041-1050 من 19182 لعملية البحث عن HIV/AIDS
Food and Drug Administration (FDA) approved for the treatment of CLL and SLL. ... virus (HR-HPV) detected in vaginal fluid and/or plasma. Optical Fusion Trans ...
... and/or positive peritoneal cytology undergoing robotic cytoreduction and hyperthermic intraperitoneal chemotherapy. A Study to Evaluate the Feasibility of ...
... positive bronchial neuroendocrine tumors that ... Radioactive drugs, such as lutetium Lu 177 dotatate, may carry radiation directly to tumor cells and may reduce ...
... and/or positive peritoneal cytology undergoing robotic cytoreduction and hyperthermic intraperitoneal chemotherapy. A Study to Evaluate Biomarker Target ...
... of indolent NHL and CLL patients, delay time to disease progression, assess the need for treatment, and assess infection rates. Pre-myeloid Cancer and Bone ...
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS. Rochester, Minn. The purpose of this ...
This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...
... and explore its value in a healthcare environment subject to cost containment. MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus ...
Parasites — Giardia. Centers for Disease Control and Prevention. https://www.cdc.gov/parasites/giardia/index.html. Accessed Nov. 3, 2020. Levinson W, et al.
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care ... of care to treat participants with HER2 positive colorectal cancer. This ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.